Atrial fibrillation (AF) is the most common heart rhythm disorder. People as young as 40 have a 1 in 4 chance of developing AF in their lifetime, making them 5 times more likely to suffer a stroke. In an effort…
As TeleCheck AF continues to gain traction across the continent, notable strides are being made in the UK, where recently published guidelines cite FibriCheck’s remote heart rhythm monitoring as an example of clinical best practice in the delivery of care for cardiovascular disease…
FibriCheck enables large scale teleconsultations at Maastricht University Medical Centre+
The CE-marked FibriCheck app is now available for download from the Samsung Galaxy Store for the recently launched Samsung Galaxy Watch3, demonstrating the technology’s true cross-platform compatibility. The FibriCheck app that helps detect potentially debilitating heart rhythm irregularities such as…
FibriCheck gains approval from Australia’s Therapeutic Goods Administration (TGA) FibriCheck, the mobile app capable of detecting heart rhythm disorders, was granted an Australian Register of Therapeutic Goods Certificate by the Australian Government Department of Health last week. As the first…
Night monitoring now closer than ever after successful beta test If you’re familiar with atrial fibrillation, you’ll know it can be a dangerous condition – the heart rhythm disorder is responsible for around 25% of all strokes1. You’ll also know…
TeleCheck-AF remote screening project goes live across Europe It’s no secret the COVID-19 pandemic is placing enormous pressure on our healthcare system. Capacity in our hospitals and clinics is stretched thin. And some patients may find it hard to get…
A world first - FibriCheck app automatically detects both silent and intermittent atrial fibrillation at night, dramatically reducing the risk of stroke in 40-plussers Hasselt, Belgium, 31 March 2020 - FibriCheck, the first CE- and FDA-approved medical app, today announces…
FibriCheck has been announced as one of 11 innovations selected to join the award-winning NHS Innovation Accelerator (NIA) in 2020 FibriCheck is thrilled to be among the new innovations joining the 2020 NIA programme. FibriCheck is an innovative, hardware-free…
Atrial fibrillation or AF is the most common heart rhythm disorder and is defined by its irregular and often accelerated heart beat. Untreated atrial fibrillation increases the chance for certain serious disorders like stroke, heart failure, diabetes, dementia and hypertension.…